Consent to the Distribution of Changed Medicines Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution inNew Zealand of the changed medicines set out in the Schedule hereto: Schedule Name and Strength Form Name and Address of Manufacturer Proprietary Name(if any) Captopril 37.5 mg Tablet Bristol-Myers Squibb Pharmaceuticals Limited, Moreton, Wirral, Merseyside, England and Bristol-Myers Squibb Australia Pty Limited, Noble Park, Victoria, Australia Capoten D Carboxymethylcellulose 5 mg/mL in 0.4 mL Drops, eye Allergan Optical, Allergan Inc., Waco, Texas, United States of America Cellufresh Triptorelin acetate 4 mg equivalent to 3.75 mg triptorelin Solution for injection, prefilled syringe Ferring AB., Malmo, Sweden and Ferring Arzneimittel GmbH., Keil, Germany Decapeptyl-CR Isosorbide mononitrate 120 mg Tablet, modified release Astra Pharmaceutical Production AB., Sodertalje, Sweden Imdur Durules Omeprazole 20 mg Capsule Astra Pharmaceutical Production AB., Sodertalje, Sweden Losec Omeprazole sodium 42.6 mg equivalent of 40 mg omeprazole in 10 mL Powder for injection (ampoule) and diluent (ampoule) Astra Pharmaceutical Production AB., Sodertalje, Sweden Losec IV Filgrastim 300 mcg in 1 mL Solution for injection (ampoule) F Hoffmann-La Roche Limited, Basle, Switzerland and Parke Davis Inc., Rochester, Michigan, United States of America Neupogen Conjugated estrogens 0.3 mg, 0.625 mg, 1.25 mg Tablets Wyeth Medica Ireland, Little Connell, Newbridge, County Kildare, Ireland and Wyeth-Ayerst Canada Inc., St Laurent, Montreal, Quebec, Canada and Wyeth-Ayerst Laboratories, Rouses Point, New York, Australia Premarin Didanosine 50 mg, 100 mg Tablet, chewable/ dispersible Bristol-Myers Squibb Co., Evansville, Indianna, United States of America Videx Dated this 12th day of April 1996. G. R. BOYD, Acting Assistant General Manager, Health Regulation & Protection, pursuant to delegation given by the Minister of Health on 18 January 1996.